A Study to Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function

NCT04414852 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Subjects With Impaired Renal Function and Healthy Subjects

Interventions

DRUG: Apatinib Mesylate

Sponsor

Jiangsu HengRui Medicine Co., Ltd.